Patent · US Expired

7.beta.-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins

US4024133A · kind A · utility

32Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 1975
Grant dateMay 17, 1977
Priority date
Expiry dateJun 16, 1995

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D499/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides novel antibiotic compounds which are 7.beta.-acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof characterized in that the acylamido group has the structure ##STR1## WHERE R is a hydrogen atom or an organic group and R.sup.a is an etherifying monovalent organic group linked to the oxygen atom through a carbon atom. The compounds are syn isomers or exist as mixtures containing at least 75% of the syn isomer. These antibiotic compounds possess high antibacterial activity against a range of gram positive and gram negative organisms coupled with particularly high stability to .beta.-lactamases produced by various gram negative organisms. The invention is also concerned with the administration of the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.